semaglutide 0.5 / Cyanocobalamin Injection OZEMPIC® 0.5mg (International English) -
Description
Lillys oral GLP-1 contender, orforglipron is also in a late-stage trial
Commercial Aetna plans may cover Mounjaro (the diabetes formulation) more readily than Zepbound (marketed for weight loss), but prior authorization is usually required
Maintain a Healthy Weight: Work towards a healthy weight to reduce the strain on your lower back
Those with weight loss resistance, insulin resistance, prediabetes, or metabolic slowdown
In practice, the FDA granted half the extension industry asked for, and nothing in the June notice suggests the agency is rethinking its position
